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background:  High risk patients with non-ST-elevation acute coronary syndromes such as NSTEMI should be considered for early invasive 
treatment. Little is known how these recommendations are implemented into clinical practice and how this might impact outcome in patients with 
NSTEMI.
methods: The OPTAMI registry (Optimized Therapy of Acute Myocardial Infarction) enrolled consecutive patients with STEMI and NSTEMI in 33 
centres (27 with cathlab) in Germany to document patient characteristics, acute therapy as well as hospital and 1-year outcome. We examined the 
impact of early coronary intervention on outcome of NSTEMI.
results: A total of 1554 patients with NSTEMI were enrolled into OPTAMI. Coronary angiography was performed in 85%, but only 989 pts (63.6%) 
did undergo PCI during this index angiography. In NSTEMI patients undergoing coronary angiography without PCI, the prevalence of multivessel 
disease (2- or 3-vessel disease) was 80%. Within this group, the rate of referral to CABG was significantly higher. Hospital mortality was significantly 
lower in patients referred to early reperfusion and remained lower after one year of follow-up as compared to patients with primary conservative 
treatment.
Conclusions: Data of the OPTAMI registry demonstrate a high rate of a primary invasive treatment strategy in Germany with 85% of patients 
referred to coronary angiography in clinical practice. Patients who underwent early PCI had significantly lower hospital and 1-year mortality. 
PCI <48h (n=989) No PCI <48h (n=565) p-value
Age (y) 68 72 <0.0001
Females 24.1% 40.7% <0.0001
Diabetes 31.1% 40.4% <0.001
Smoking 30.0% 24.1% <0.05
Hypertension 77.6% 81.2% 0.09
Hyperlipidemia 49.1% 47.8% 0.62
Prior MI 28.0% 50.3% <0.001
Prior PCI 27.0% 26.6% 0.90
Prior CABG 12.0% 11.9% 0.97
Prior stroke 6.5% 12.4% <0.0001
Renal failure 17.1% 25.5% <0.0001
Coro Angio 100% 60% <0.0001
1-vessel disease 32.8% 19.8% <0.0001
2-vessel disease 35.2% 19.0% <0.0001
3-vessel disease 32.0% 61.1% <0.0001
Emergency CABG 0.7% 10.5% <0.0001
Hospital mortality 3.2% 9.5% <0.0001
1-year mortality 10.9% 24.3% <0.0001
